Carcinoma News and Research

RSS

Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.

What is Telomere crisis?

Telomere crisis is an important early event in the development of breast cancer, and its occurrence can be identified with precision, according to recent findings by a team of scientists at the Department of Energy's Lawrence Berkeley National Laboratory and the University of California at San Francisco.

11 Aug 2004

Advances in biomedical imaging could lead to more sensitive screening tests for cancer-fighting drugs

Advances in biomedical imaging are allowing UC Davis researchers to use mice more effectively to study cancers comparable to human disease. The system can distinguish different stages of cancer and could lead to more sensitive screening tests for cancer-fighting drugs.

9 Aug 2004

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Radiation therapy (RT) has been the most important treatment modality with curative potential in treating patients with cancer of the nasopharynx, the part of the pharynx that lies above the soft palate.

9 Aug 2004

Alterations in a tumor suppressor gene called p53 are more prevalent in breast cancer of African-American women than white women

Ethnic differences in the incidence and mortality rates of breast cancer are noted in the United States and worldwide. In the U.S., the most apparent differences are seen between African-American and white women. African-American women have lower incidence rates of the disease, but have higher mortality rates. Moreover, African-American women present at a younger age and with more aggressive disease.

9 Aug 2004

Research to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide

A University of Queensland researcher has been awarded $850,000 by one of Australia’s largest private, charitable, medical foundations to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide.

29 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

20 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Potential new strategy for blocking tumor growth

Targeting a master molecule that helps cancer cells survive when blood oxygen levels are low may offer a potentially powerful strategy for blocking tumor growth, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Jun 2004

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

A new multi-targeted anticancer drug called SU11248 has shown very promising results in the treatment for metastatic renal cell cancer, one of the most chemotherapy resistant of all cancers.

6 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.

2 Jun 2004

Marijuana use does not appear to be associated with an increased risk of developing oral cancer

Contrary to previous research findings that have suggested a link, marijuana use does not appear to be associated with an increased risk of developing oral cancer, according to a large, population-based study led by researchers at Fred Hutchinson Cancer Research Center.

1 Jun 2004

Clinical trial of 5 day treatment for earliest form of breast cancer

Researchers at Virginia Commonwealth University’s Massey Cancer Center have begun a clinical trial testing the effectiveness of an established balloon catheter radiation delivery device on the earliest form of breast cancer, ductal carcinoma in situ.

27 May 2004

Largest study ever finds male breast cancer on the rise

The rate of male breast cancer is on the rise and the disease in men is usually detected when the tumors are bigger, have spread and may be more aggressive, compared to diagnosis of the disease in women, concludes the largest study ever conducted of male breast cancer.

24 May 2004

Study finds breast cancer in men is increasing though the disease remains rare

The largest study to date of male breast cancer finds, contrary to previous reports, breast cancer rates in men are increasing though the disease remains rare.

23 May 2004

New study of tumor genetics may help to treat patients with head and neck cancer

Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.

19 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Screening for liver diseases benefits outweigh costs for some, but not all, conditions

Screening programs for liver diseases can detect asymptomatic conditions which might have better outcomes if diagnosed and treated earlier.

14 May 2004

Carcinoma News and Research

Further Reading

What is Telomere crisis?

Advances in biomedical imaging could lead to more sensitive screening tests for cancer-fighting drugs

Aggressive treatment for nasopharyngeal cancer shown to be more effective

Alterations in a tumor suppressor gene called p53 are more prevalent in breast cancer of African-American women than white women

Research to develop ways to inhibit head and neck cancers, the fifth most common cancer worldwide

New cream treatment for common form of skin cancer

Bladder-sparing treatment shows promise against cancer

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

3M granted FDA approval for cream to treat superficial basal cell carcinoma

Potential new strategy for blocking tumor growth

Multi-targeted anticancer drug shows promise as treatment for metastatic renal cell cancer

Drug Tarceva improves survival chance for patients with advanced lung cancer

Avastin study shows significant improvement in patients with metastatic colorectal cancer

Marijuana use does not appear to be associated with an increased risk of developing oral cancer

Clinical trial of 5 day treatment for earliest form of breast cancer

Largest study ever finds male breast cancer on the rise

Study finds breast cancer in men is increasing though the disease remains rare

New study of tumor genetics may help to treat patients with head and neck cancer

Interventional radiologists now are able to treat using minimally invasive procedures

Screening for liver diseases benefits outweigh costs for some, but not all, conditions

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News